Home - News - UNN scientists discover new characteristics of bee venom and bee products

26 June 2017

Researchers  of the UNN Institute of Biology and Biomedicine (IBBM) have established as a result of laboratory tests that bee venom and bee products inhibit the growth of malignant tumors, enhance biological activity of the body, and can also be used to treat diabetes mellitus.

Anna Deryugina, Head of the Department of Physiology and Anatomy of the UNN IBBM explains: “Currently, we are continuing the tests of a chemical compound including chitosan, gold nanoparticles and bee venom, in particular, in relation to the treatment of oncological diseases.   We have found out that the compound synthesized by our colleagues at the UNN Faculty of Chemistry inhibits the growth of malignant tumors. Our institute has been testing this compound on rats for several years. This process takes quite a while, as always in medical tests. We look forward to the day in the future  when cancer patients will be treated with beekeeping products, but athletes can already use these substances to enhance their performance and set records.”  

“This is a permitted biostimulator, which increases physical potential”,  continues Anna Deryugina. – “In particular, we are talking about royal jelly and propolis. We have also proved that bee venom can be used in the treatment of diabetes mellitus.  Strange as it may seem, bee venom lowers the amount of sugar in the blood.  Royal jelly and honey also reduce the sugar level. These drugs can be used for type 2 diabetes mellitus. They can also be used for type 1 diabetes, but with a much weaker effect. Of course, it is best to use royal jelly and honey for prevention, when the blood sugar level has not crossed the critical line.”

Currently, UNN researchers are working to determine an effective dose of bee products. However, there are no doubts that  bee venom and bee products can be used as  biologically active additives to correct certain states of the human body.

"Our tests are especially important for the treatment of oncological diseases and diabetes mellitus,  because they share  the second place among the causes of death and are second only to cardiovascular diseases,” - concludes the expert.